PATENT CLAIM ANALYSIS

Application Number: 16091699
Application Type: Utility
Filing Date: 2018-10
Publication Date: 2019-09
Patent Classification: ["514", "456000"]

Abstract:
A method for providing isoflavonoid compounds to the central nervous system comprising the step of rectally administering the compound to an individual in need thereof. This method is useful in the treatment of brain cancers, including glioblastoma multiforme.

Claim (Index 14):
The method of  claim 10  wherein the compound of general formula (I) is provided to the individual to sensitise the cancer cells of the individual to the cytotoxic effects of temozolomide.

Metadata:
- Claim Count in Document: 22.0
- Percentile: 97.0
- Lexical Diversity: 1.24242
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15714647', '11909538', '15968462', '13907427', '11303854']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7574835165764338
- 35 USC 102 Novelty (BERT): 0.4832117353618405
- Combined Prediction Score: 0.7300563384549744
- Mean Citation Score: 174.40313799999996
- Max Citation Score: 178.48242
- Similarity Product: 128.02200327736617

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test